Friday, September 15, 2017
| Hours | Subject | Speaker |
|---|---|---|
| 12:00 – 15:15 | Postgraduate Course Educational Lectures | Chairs: K. Dardoufas, A. Vlastou |
| 12:00 – 12:30 | Head and neck surgery | D. Moraitis |
| 12:30 – 13:00 | Principles of radiotherapy | Κ. Tsamasioti |
| 13:00 – 13:30 | Molecular targets and targeted therapies | P. Bossi |
| 13:30 – 14:00 | Principles of cancer immunology | C.N. Baxevanis |
| 14:00 – 15:15 | Working Lunch | |
| 15:15 – 16:10 | Round Table: HPV positive oropharyngeal cancer | Chairs: E. Petinellis, D. Moraitis |
| 15:15 – 15:30 | HPV infection | Ε. Patrozou |
| 15:30 – 15:45 | Robotic surgery for the oropharynx | G. Garas |
| 15:45 – 16:00 | Combined modality approaches in clinical trials | S. Nuyts |
| 16:00 – 16:10 | Panel Discussion | |
| 16:10 – 17:30 | Invited Lectures | Chairs: G. Strantzalis, N. Salvaras |
| 16:10 – 16:30 | Locally advanced neoplasms of sinus: Experience with multimodality approach |
Ch. Georgalas |
| 16:30 – 16:50 | Current head and neck cancer clinical trials in the UK | I. Nixon-Frangandrea |
| 16:50 – 17:10 | The role of pathologist in evaluating surgical specimens | Α. Lazaris, G. Agrogiannis |
| 17:10 – 18:10 | Coffee Break | |
| 18:10 – 19:10 | Round Table: Oral cavity cancer | Chairs: Α. Rapidis, K. Papakonstantinou |
| 18:10 – 18:25 | Premalignancy and early detection | N. Nikitakis |
| 18:25 – 18:40 | Reconstructive surgery in oral cavity cancer | J. I. Helman |
| 18:40 – 18:55 | Combined modality therapy | Ch. Christopoulos |
| 18:55 – 19:10 | Panel Discussion | |
| 19:10 – 19:40 | Invited Lecture | Chairs: E. Petinellis, K. Papakostas |
| 19:10 – 19:40 | Neck carcinoma of unknown primary: Diagnosis and treatment in the HPV era |
P. Nicolai |
| 19:40 – 20:10 | Keynote Lecture | Chairs: C. Georgalas, K. Dardoufas |
| Present and future of head and neck cancer immunotherapy | A. Argiris Sponsored by BMS | |
| 20:10 – 20:20 | Welcome Address – Opening Ceremony | HeSHNO Board |
| 20:20 | Cocktail Reception |
Saturday, September 16, 2017
| Hours | Subject | Speaker |
|---|---|---|
| 09:00 – 10:00 | Invited Lectures | Chairs: Μ. Tolia, E. Hatzimanolis |
| 09:00 – 09:20 | Surgical management of skin cancer in the head and neck | A. Karkanevatos |
| 09:20 – 09:40 | Management of thyroid cancer | Ι. Hajiioannou |
| 09:40 – 10:00 | Nasopharyngeal cancer: Role of chemotherapy | P. Katsaounis |
| 10:00 – 11:15 | Round Table: Locally recurrent disease | Chairs: A. Giannopoulou, Μ. Panteliadou |
| 10:00 – 10:20 | Salvage surgery | P. Nicolai |
| 10:20 – 10:40 | Re-irradiation with or without chemotherapy | J. Lovey |
| 10:40 – 11:00 | Systemic therapy | P. Gouveris |
| 11:00 – 11:15 | Panel Discussion | |
| 11:15 – 11:30 | Coffee Break | |
| 11:30 – 12:30 | Round Table: Laryngeal and hypopharyngeal cancers | Chairs: I. Bizakis, M. Koukourakis |
| 11:30 – 11:50 | Surgical considerations in laryngeal cancer | K. Papakostas |
| 11:50 – 12:10 | Radiotherapy for early and advanced stage cancers | Ch. Christopoulos |
| 12:10 – 12:30 | Induction chemotherapy in combined modality approaches | A.F. Castro |
| 12:30 – 13:45 | Round Table: Supportive care | Chairs: M. Balafouta, D. Katsochi |
| 12:30 – 12:50 | Nutritional evaluation and support | I. Gioulbasanis |
| 12:50 – 13:10 | Physical therapy for functional complications | Ν. Kakargia |
| 13:10 – 13:30 | The role of stomatologist | D. Malamos |
| 13:30 – 13:45 | Panel Discussion | |
| 13:45 – 16:00 | Lunch | |
| 13:45 – 16:00 | In room: HeSHNO General Assembly and Board Election (HeSHNO members only) |
|
| 16:00 – 16:50 | Round Table: Molecularly targeted therapies | Chairs: Ch. Christodoulou, P. Katsaounis |
| 16:00 – 16:20 | EGFR-targeted therapies | P. Szturz |
| 16:20 – 16:40 | Anti-angiogenesis and other emerging therapies | C. Le Tourneau |
| 16:40 – 16:50 | Panel Discussion | |
| 16:50 – 17:50 | Multidisciplinary Tumor Board | Moderator: A. Argiris Panelists: S. Nuyts, J. Lovey, D. Moraitis, P. Szturz |
| 17:50 – 18:10 | Coffee Break | |
| 18:10 – 19:40 | Round Table: Immunotherapy for HNC | Chairs: V. Georgoulias, A. Argiris |
| 18:10 – 18:30 | Immune mechanisms and therapeutic targets | Ο. Tsitsilonis |
| 18:30 – 18:50 | Clinical applications of immune checkpoint inhibitors in recurrent/metastatic disease |
G. Lazaridis |
| 18:50 – 19:10 | Combinations of immune checkpoint inhibitors with chemotherapy and/or radiotherapy; ongoing and planned trials in locally advanced disease |
J. Bourhis |
| 19:10 – 19:30 | Emerging immune biomarkers | Α. Kotsakis |
| 19:30 – 19:40 | Panel Discussion | |
| 19:40 – 19:45 | Closing Remarks | HeSHNO Board |